BioCentury
ARTICLE | Financial News

Intercept proposes $63.3M follow-on

June 11, 2013 1:36 AM UTC

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) proposed on Monday to raise up to $63.3 million through the sale of up to 2 million shares in a follow-on. BofA Merrill Lynch; Citigroup; BMO Capital Markets; Needham; Wedbush; and Janney Montgomery Scott are underwriters. The biotech was down $1.36 to $32.29 on Monday. ...